Alisa Lask - 10 Aug 2022 Form 4 Insider Report for RVL Pharmaceuticals plc (RVLP)

Role
Director
Signature
/s/ Christopher Klein, as attorney-in-fact
Issuer symbol
RVLP
Transactions as of
10 Aug 2022
Net transactions value
$0
Form type
4
Filing time
12 Aug 2022, 16:07:32 UTC
Previous filing
16 Dec 2021
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVLP Ordinary Shares Award $0 +75,000 +785% $0.000000 84,557 10 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units.